Long term performance and safety of His bundle pacing: A multicenter experience.


Journal

Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756

Informations de publication

Date de publication:
09 2019
Historique:
received: 26 04 2019
revised: 20 06 2019
accepted: 23 06 2019
pubmed: 17 7 2019
medline: 6 10 2020
entrez: 17 7 2019
Statut: ppublish

Résumé

Several single-center short-term studies have demonstrated the feasibility, safety, and positive clinical outcomes of permanent His bundle pacing (HBP). We performed a retrospective study to evaluate long-term technical and safety performances of HBP in a large population of pacemaker patients from two different centers. The analysis includes 844 patients (345 female, mean age = 75 ± 9 years) who underwent successful permanent HBP for pacemaker indications from 2004 to 2016. The main endpoints were long term electrical performances including pacing threshold, sensing, impedance, and freedom from pacing related complications. The pacing indication was AV Block in 348 (41.2%) patients, sinus node disease in 147 (17.4%), any bradycardia indication in patients with atrial fibrillation in 335 (39.7%) patients and need for cardiac resynchronization therapy in 14 (1.7%) patients. Mean pacing capture thresholds and sensed R waves were 1.6 V and 5.8 mV, respectively at implant and 2.0 V and 6.1 mV at chronic follow-up. During the median follow up of 3 years (interquartile range = 1-6 years), HBP was free of any complication in 91.6% of patients. In the first 368 patients, HBP was achieved using a deflectable curve delivery system, while in 476 using the fixed curve sheath. A significant difference was found in the thresholds (2.4 ± 1.0 V and 1.7 ± 1.1 V, P < .001, respectively) and complications (11.9% and 4.2%, P < .001, respectively) between the two groups. Permanent HBP was safe and effective during long-term follow-up. The fixed curved delivery sheath offered significantly better electrical parameters and reliability over time. The results of this multicenter study are consistent with recent studies.

Identifiants

pubmed: 31310410
doi: 10.1111/jce.14063
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1594-1601

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Francesco Zanon (F)

Cardiology Department, Arrhythmia and Electrophysiology Unit, Santa Maria Della Misericordia Hospital, Rovigo, Italy.

Mohamed Abdelrahman (M)

Department of Cardiac Electrophysiology, Geisinger Heart Institute, Wilkes-Barre, Pennsylvania.

Lina Marcantoni (L)

Cardiology Department, Arrhythmia and Electrophysiology Unit, Santa Maria Della Misericordia Hospital, Rovigo, Italy.

Angela Naperkowski (A)

Department of Cardiac Electrophysiology, Geisinger Heart Institute, Wilkes-Barre, Pennsylvania.

Faiz A Subzposh (FA)

Department of Cardiac Electrophysiology, Geisinger Heart Institute, Wilkes-Barre, Pennsylvania.

Gianni Pastore (G)

Cardiology Department, Arrhythmia and Electrophysiology Unit, Santa Maria Della Misericordia Hospital, Rovigo, Italy.

Enrico Baracca (E)

Cardiology Department, Arrhythmia and Electrophysiology Unit, Santa Maria Della Misericordia Hospital, Rovigo, Italy.

Graziano Boaretto (G)

Cardiology Department, Arrhythmia and Electrophysiology Unit, Santa Maria Della Misericordia Hospital, Rovigo, Italy.

Paola Raffagnato (P)

Cardiology Department, Arrhythmia and Electrophysiology Unit, Santa Maria Della Misericordia Hospital, Rovigo, Italy.

Antonella Tiribello (A)

Cardiology Department, Arrhythmia and Electrophysiology Unit, Santa Maria Della Misericordia Hospital, Rovigo, Italy.

Gopi Dandamudi (G)

Department of Cardiac Electrophysiology, Geisinger Heart Institute, Wilkes-Barre, Pennsylvania.

Pugazhendhi Vijayaraman (P)

Department of Cardiac Electrophysiology, Geisinger Heart Institute, Wilkes-Barre, Pennsylvania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH